Upcoming Events


Applying Nanovial Technology to Discover Rare T Cell Receptors
Mar
20

Applying Nanovial Technology to Discover Rare T Cell Receptors

“Lab on a particle” technologies, such as Nanovials, are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell sequencing platforms. Learn about our progress in using Nanovial particles for discovery of monoclonal antibodies and the characterization and discovery of antigen-specific and metabolite-specific T cells.

View Event →
Accelerating the Discovery of Monoclonal Antibodies (mAbs) and T-cell Receptors (TCRs) using Lab on a Particle Technology
Feb
6

Accelerating the Discovery of Monoclonal Antibodies (mAbs) and T-cell Receptors (TCRs) using Lab on a Particle Technology

“Lab on a particle” technologies, such as Nanovials, are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell sequencing platforms. Learn about our progress in using Nanovial particles for discovery of monoclonal antibodies and the characterization and discovery of antigen-specific and metabolite-specific T cells.

View Event →
Fully Human Antibody Discovery Using Nanovials and Plasma Cells From ATX-GKTM Mice
Dec
7

Fully Human Antibody Discovery Using Nanovials and Plasma Cells From ATX-GKTM Mice

Pairing Alloy Therapeutics’ best-in-class transgenic humanized mouse with Partillion Biosciences’ Nanovial technology provides a simple and cost-efficient method to perform high throughput screens of antibody secreting plasma cells for the discovery of antigen-specific antibodies. In this webinar, we demonstrate an antibody discovery workflow that yields diverse, high affinity binders with development potential in therapeutic settings.

View Event →
Accelerating the Discovery of Rare Antibodies and T-cell Receptors (TCRs) using Lab on a Particle Technology
Nov
30

Accelerating the Discovery of Rare Antibodies and T-cell Receptors (TCRs) using Lab on a Particle Technology

“Lab on a particle” technologies, such as Nanovials, are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell sequencing platforms. Learn about our progress in using Nanovial particles for discovery of monoclonal antibodies and the characterization and discovery of antigen-specific and metabolite-specific T cells.

View Event →
Caltech Bioscience Industry Day 2023
Nov
16

Caltech Bioscience Industry Day 2023

Come say hi at the Caltech Bioscience Industry Day, a flagship event of the Caltech Bioscience Industrial Partners Program (CBIPP), for a day of inspiring discussions, industry connections, and cutting-edge innovations in biodata, biopharma, biotech, life sciences, medical devices, and synthetic biology.

View Event →